UK regulators say people with a “significant medical history” of allergic reactions should not receive the new Pfizer vaccine.
FILE – On May 4, 2020, a data photo from the University of Maryland School of Medicine shows the first patient to participate in a clinical trial of the Pfizer COVID-19 coronavirus vaccine at the University of Maryland School of Medicine in Baltimore. The Pfizer COVID-19 vaccine is entering the final phase of a review of U.S. government regulations. The Food and Drug Administration issued a positive opinion on the vaccination on Tuesday, December 8th.
LONDON (AP) – UK regulators say people with a “significant medical history” of allergic reactions should not be given the new Pfizer / BioNTech vaccine while examining two side effects that occurred on the first day of the country’s mass vaccination program.
Professor Stephen Powis, National Medical Director for the National Health Service in England, said health authorities are acting on the recommendation of the Agency for Medicines and Health Products, the country’s drug regulator. He said the MHRA advised as a precaution that people with a significant history of allergic reactions should not receive this vaccine. He said both people are recovering well.
The Food and Drug Administration will meet tomorrow to decide if there is a need for emergency use in the United States. An analysis by FDA scientists on Tuesday released its first scientific assessment of Pfizer’s COVID-19 vaccine, confirming that it provides strong protection, laying the groundwork for the government’s green light to make the nation’s biggest vaccination effort.
COPYRIGHT 2020. ALL RIGHTS RESERVED. THIS MATERIAL CANNOT BE RELEASED, REPRODUCED, rewritten, or redistributed.
